29462-18-8 Usage
Originator
Bentazepam,Laboratorios Made S. A.
Uses
Sedative-hypnotic.
Manufacturing Process
To a solution of 3.4 kg N-phthalimidoacetic acid in 20 L of methylene chloride
was added a solution of 2.8 kg of 1,1-carbonyl diimidazol in 20 L of methylene
chloride. The mixture was refluxed for 1 hour. After cooling to the obtained
solution was added a solution of 4.3 kg of 2-amino-3-benzoyl-4,5-
tetramethylene thiophene in 30 L of methylene chloride and the reaction
mixture was refluxed for 16 hours. After cooling the mixture was washed with
30 L of water, dried with sodium sulfate and filtered. After removing the
solvent was obtained the 2-(N-phthalimidoacetylamino)-3-benzoyl-4,5-
tetramethylene thiophene, yield 70%, melting point 230°C.
Therapeutic Function
Anticonvulsant, Tranquilizer
Safety Profile
Moderately toxic by ingestion andintraperitoneal routes. When heated to decomposition itemits toxic fumes of SOx and NOx.
Check Digit Verification of cas no
The CAS Registry Mumber 29462-18-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,9,4,6 and 2 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 29462-18:
(7*2)+(6*9)+(5*4)+(4*6)+(3*2)+(2*1)+(1*8)=128
128 % 10 = 8
So 29462-18-8 is a valid CAS Registry Number.
InChI:InChI=1/C17H16N2OS/c20-14-10-18-16(11-6-2-1-3-7-11)15-12-8-4-5-9-13(12)21-17(15)19-14/h1-3,6-7,18H,4-5,8-10H2
29462-18-8Relevant articles and documents
Synthesis and pharmacological evaluation of 2,3 dihydro 1H thieno[2,3 e][1,4]diazepines
Tinney,Sanchez,Nogas
, p. 624 - 630 (2007/10/05)
A series of 2,3 dihydro 1H thieno[2,3 e][1,4]diazepines was synthesized and evaluated for CNS activity. A new antianxiety screen for benzodiazepine like drugs was used along with the standard anticonvulsant test. Structure activity relationships are discussed. One compound, 1,3,6,7,8,9 hexahydro 5 phenyl 2H [1]benzothieno[2,3 e][1,4]diazepin 2 one monosulfate (CI 718), is undergoing clinical studies in man.